The Experienced U.S. Partner for Diagnostic Innovators
We bring decades of U.S. diagnostics market experience to international manufacturers who are ready to compete in the world's most demanding healthcare market.
Bridging Innovation and Market Access
The U.S. diagnostics market represents the largest and most complex opportunity in global healthcare. Navigating it requires more than a good product — it demands deep market knowledge, established relationships, and the ability to move with precision through a landscape of regulatory requirements, reimbursement structures, and competitive dynamics that are unlike any other market in the world.
NeoMark Ventures was founded to give international diagnostic manufacturers a genuine competitive advantage in the U.S. market. We serve as the experienced commercial partner that most international manufacturers cannot build on their own — providing the strategic guidance, market access, and hands-on support needed to move from opportunity to commercial success.
"We don't just advise — we work alongside our clients as their U.S. commercial partner, with accountability for outcomes."
Eric A. Button
Founder & CEO, NeoMark Ventures
Eric A. Button is an experienced diagnostics industry executive with a track record of working with international manufacturers to introduce innovative clinical laboratory technologies into the United States. He is also the Founder and CEO of Precision Diabetes, Inc., a specialty diagnostics company with extensive experience collaborating with overseas manufacturers and commercializing innovative diagnostic biomarkers.
His background combines scientific expertise, executive leadership, international business development, and practical experience navigating the commercial challenges of the U.S. clinical diagnostics market. NeoMark Ventures offers international manufacturers a trusted, experienced partner focused on turning promising diagnostic technologies into realistic U.S. commercial opportunities.
MBA, University of North Carolina
Master of Science in Molecular Genetics, University of British Columbia
Advanced training in medical statistics, Stanford University
Founder & CEO, Precision Diabetes, Inc.
Proven track record introducing international diagnostic technologies to the U.S. market
Disciplined. Relationship-Driven. Results-Oriented.
Every engagement begins with a rigorous assessment of the opportunity and a clear-eyed view of the challenges. We do not oversell the U.S. market — we help our clients understand it accurately and enter it strategically.
Honest Assessment First
Before recommending a path forward, we conduct a thorough commercial feasibility assessment. If the market opportunity is not yet ready, we say so — and we help our clients prepare.
Relationships That Open Doors
Our value is not just strategic advice — it is access. We bring established relationships across the U.S. diagnostics ecosystem that take years to build and cannot be replicated from outside the market.
Accountability for Outcomes
We measure our success by our clients' commercial progress. Every engagement is structured around clear objectives, defined milestones, and a shared commitment to results.
Ready to Explore the U.S. Market?
Contact us to discuss how NeoMark Ventures can support your U.S. market entry or expansion objectives.